Broad Institute

Propelling the understanding and treatment of disease

Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease

Collaborating deeply

Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world

Reaching globally

Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries

Empowering scientists

Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential

Building partnerships

Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer

Sharing data and knowledge

Broad Institute is committed to making the extensive data, methods, and technologies it generates rapidly and readily accessible to the scientific community to drive biomedical progress around the world

Promoting inclusion

Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity

INSIDE BROAD

News / 11.26.19

New diagnostic approach rapidly identifies the right antibiotics

GoPhAST-R could one day help patients get the most effective treatment faster, while slowing the spread of antibiotic-resistant superbugsRead more

News / 11.22.19

How the immune system puts the brakes on allergic inflammation

Two studies in mice reveal a cellular circuit that inhibits inflammation in the intestine and lungs.Read more

News / 11.12.19

Curbing inflammation could reduce heart disease risk linked to blood disorder

The finding suggests a potentially more targeted way to treat certain patients with the disorder, called CHIP, which commonly affects the elderlyRead more

News / 11.22.19

Research Roundup: November 22, 2019

Delving into anti-inflammatory molecular crosstalk, heart-stopping genetics, prostate cancer drug resistance, and moreRead more

News / 11.1.19

New genomic regions linked to common vascular disorder

A large genetic study of venous thromboembolism could lead to better ways of identifying and treating people at high risk for the disease.Read more

News / 11.19.19

Novo Ventures and Broad Institute of MIT and Harvard launch drug discovery “Greenhouse” to drive creation of innovative new therapies

Partnership supports groundbreaking science through critical early stages of drug discoveryRead more

News / 10.23.19

Potential blood test for tuberculosis shows early promise

A simple test measuring five proteins could one day be used to triage patients with TB around the world.Read more

News / 10.21.19

New CRISPR genome editing system offers a wide range of versatility in human cells

“Prime editing” combines two key proteins and a new RNA to make targeted insertions, deletions, and all possible single-letter changes in the DNA of human cellsRead more

News / 10.17.19

Imaging combined with genetic screening of cells enhances genomic discoveries

New image-based genetic screening method helps researchers identify key regulators of inflammation.Read more

News / 10.10.19

CRISPR enzyme programmed to kill viruses in human cells

Researchers harness Cas13 as an antiviral and diagnostic for RNA-based virusesRead more

News / 10.8.19

Large study reveals PTSD has a strong genetic component like other psychiatric disorders

Researchers studying genetic data from 200,000 people have found that the heritability of post-traumatic stress disorder is similar to that of depression and other forms of mental illness.Read more